Expectations and Level of Satisfaction of the Patient with Parkinson’s Disease Undergoing Deep Brain Stimulation Surgery at the National Institute of Neurology and Neurosurgery
Background: Deep brain stimulation (DBS) is an established treatment for patients with advanced Parkinson’s disease (PD). Reports show continued patient satisfaction after surgery despite not maintaining clinical improvement as measured by evolution scales. Objectives: The present study sought to explore expectations and level of satisfaction in patients after DBS surgery with a semi-structured questionnaire and subsequent correlation with functional scales, Quality of Life (QoL), and motor and non-motor symptoms. Methods: We performed descriptive statistics to represent demographic data, Wilcoxon rank tests to determine significant differences, and Spearman correlation between the applied scales. Results: We evaluated 20 patients with a history of DBS surgery. 45% were female, with a mean age of 55.7 ± 14.15 years, a mean disease duration of 13.42 ± 8.3 years, and a mean time after surgery of 3.18 ± 1.86 years. Patients reported surgery meeting expectations in 85.5% and continued satisfaction in 92%. These two variables showed a significant correlation. Conclusions: This sample of patients remained satisfied after DBS surgery, although we found no differences in motor and non-motor clinimetric scales. Further studies are needed to confirm the importance of assessing quality of life in patients with DBS.
References
[1]
Poewe, W., Seppi, K., Tanner, C.M., Halliday, G.M., Brundin, P., Volkmann, J., et al. (2017) Parkinson Disease. Nature Reviews Disease Primers, 3, Article No. 17013. https://doi.org/10.1038/nrdp.2017.13
[2]
Balestrino, R. and Schapira, A.H.V. (2020) Parkinson Disease. European Journal of Neurology, 27, 27-42. https://doi.org/10.1111/ene.14108
[3]
Feigin, V.L., Nichols, E., Alam, T., Bannick, M.S., Beghi, E., Blake, N., et al. (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480.
[4]
Ou, Z., Pan, J., Tang, S., Duan, D., Yu, D., Nong, H., et al. (2021) Global Trends in the Incidence, Prevalence, and Years Lived with Disability of Parkinson’s Disease in 204 Countries/Territories from 1990 to 2019. Frontiers in Public Health, 9, Article ID: 776847. https://doi.org/10.3389/fpubh.2021.776847
[5]
Dorsey, E.R., Sherer, T., Okun, M.S. and Bloemd, B.R. (2018) The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinson’s Disease, 8, S3-S8. https://doi.org/10.3233/JPD-181474
[6]
Church, F.C. (2021) Review Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease. Biomolecules, 11, Article No. 612. https://doi.org/10.3390/biom11040612
[7]
Dietrichs, E. and Odin, P. (2017) Algorithms for the Treatment of Motor Problems in Parkinson’s Disease. Acta Neurologica Scandinavica, 136, 378-385. https://doi.org/10.1111/ane.12733
[8]
Krauss, J.K., Lipsman, N., Aziz, T., Boutet, A., Brown, P., Chang, J.W., et al. (2021) Technology of Deep Brain Stimulation: Current Status and Future Directions. Nature Reviews Neurology, 17, 75-87. https://doi.org/10.1038/s41582-020-00426-z
[9]
Mansouri, A., Taslimi, S., Badhiwala, J.H., Witiw, C.D., Nassiri, F., Odekerken, V.J.J., et al. (2018) Deep Brain Stimulation for Parkinson’s Disease: Meta-Analysis of Results of Randomized Trials at Varying Lengths of Follow-Up. Journal of Neurosurgery, 128, 1199-1213. https://doi.org/10.3171/2016.11.JNS16715
[10]
Mahlknecht, P., Foltynie, T., Limousin, P. and Poewe, W. (2022) How Does Deep Brain Stimulation Change the Course of Parkinson’s Disease? Movement Disorders, 37, 1581-1592. https://doi.org/10.1002/mds.29052
[11]
Umemura, A., Oka, Y., Yamamoto, K., Okita, K., Matsukawa, N. and Yamada, K. (2011) Complications of Subthalamic Nucleus Stimulation in Parkinson’s Disease. Neurologia Medico-Chirurgica, 51, 749-755. https://doi.org/10.2176/nmc.51.749
[12]
Blomstedt, P. and Bjartmarz, H. (2012) Intracerebral Infections as a Complication of Deep Brain Stimulation. Stereotactic and Functional Neurosurgery, 90, 92-96. https://doi.org/10.1159/000335712
[13]
Lin, H.Y., Hasegawa, H., Mundil, N., Samuel, M. and Ashkan, K. (2019) Patients’ Expectations and Satisfaction in Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: 6-Year Follow-Up. World Neurosurgery, 121, E654-E660. https://doi.org/10.1016/j.wneu.2018.09.181
[14]
Chaudhuri, K.R., Martinez-Martin, P., Brown, R.G., Sethi, K., Stocchi, F., Odin, P., et al. (2007) The Metric Properties of a Novel Non-Motor Symptoms Scale for Parkinson’s Disease: Results from an International Pilot Study. Movement Disorders, 22, 1901-1911. https://doi.org/10.1002/mds.21596
[15]
Martinez-Martin, P., Rodriguez-Blazquez, C., Alvarez-Sanchez, M., Arakaki, T., Bergareche-Yarza, A., Chade, A., et al. (2013) Expanded and Independent Validation of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Journal of Neurology, 260, 228-236. https://doi.org/10.1007/s00415-012-6624-1
[16]
Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R. and Hyman, N. (1997) The Parkinson’s Disease Questionnaire (PDQ-39): Development and Validation of a Parkinson’s Disease Summary Index Score. Age and Ageing, 26, 353-357. http://ageing.oxfordjournals.org/ https://doi.org/10.1093/ageing/26.5.353
[17]
Hoops, S., Nazem, B.S., Siderowf, B.A.D., Duda, J.E., Xie, S.X., Stern, M.B., et al. (2009) Validity of the MoCA and MMSE in the Detection of MCI and Dementia in Parkinson Disease. Neurology, 73, 1738-1745. https://doi.org/10.1212/WNL.0b013e3181c34b47
[18]
Hasegawa, H., Samuel, M., Douiri, A. and Ashkan, K. (2014) Patients’ Expectations in Subthalamic Nucleus Deep Brain Stimulation Surgery for Parkinson Disease. World Neurosurgery, 82, 1295-1299.E2. https://doi.org/10.1016/j.wneu.2014.02.001
[19]
Maier, F., Lewis, C.J., Horstkoetter, N., Eggers, C., Kalbe, E., Maarouf, M., et al. (2013) Patients’ Expectations of Deep Brain Stimulation, and Subjective Perceived Outcome Related to Clinical Measures in Parkinson’s Disease: A Mixed-Method Approach. Journal of Neurology, Neurosurgery and Psychiatry, 84, 1273-1281. https://doi.org/10.1136/jnnp-2012-303670
[20]
Maier, F., Lewis, C.J., Horstkoetter, N., Eggers, C., Dembek, T.A., Visser-Vandewalle, V., et al. (2016) Subjective Perceived Outcome of Subthalamic Deep Brain Stimulation in Parkinson’s Disease One Year after Surgery. Parkinsonism & Related Disorders, 24, 41-47. https://doi.org/10.1016/j.parkreldis.2016.01.019